Metagenomi, Inc. Common Stock

MGX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$20-$20-$25-$23
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$3$3
Change in WC-$6-$8-$2-$15
Other Non-Cash$3$5$0$8
Operating Cash Flow-$21-$21-$23-$26
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$6-$19-$22-$12
Inv. Sales/Matur.$34$38$47$41
Other Inv. Act.$0$0$0$0
Investing Cash Flow$27$19$25$29
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$0
Financing Cash Flow-$0-$0-$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$6-$2$2$2
Supplemental Information
Beg. Cash$27$29$33$30
End Cash$33$27$34$33
Free Cash Flow-$21-$21-$23-$27